Finger-Prick test could replace needles for cancer blood monitoring

NCT ID NCT06183151

Terminated Diagnosis Sponsor: Entia Ltd Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 30, 2026 · Updated 3 times

Summary

This study tests a new device that measures blood counts from a tiny finger-prick sample in cancer patients. Researchers will compare these results to standard lab tests from regular blood draws. The goal is to see if the device is accurate enough to eventually allow patients to monitor their blood counts more easily, possibly at home. The study involves 150 adults receiving cancer therapy and is currently on hold.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Entia Liberty System (device)
What this could lead to: If successful, this could lead to a simple finger-prick test for cancer patients to monitor their blood counts at home, reducing clinic visits.
What could go wrong: This is an early-stage device validation study with only 150 participants. The results are for research only and won't change patient care yet. The study is currently suspended.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER MEDICAL DEVICE PERFORMANCE

Contacts and locations

Locations

Baylor Scott & White - Temple

Temple, Texas, 76508, United States
North Wales Clinical Research Facility

Wrexham, Wrexham County Borough, LL13 7YP, United Kingdom
Queen Margaret Hospital

Dunfermline, Fife, KY12 0SU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.